McIlvennan Colleen K, Lindenfeld JoAnn, Kao David P
Division of Cardiology, School of Medicine, University of Colorado, Aurora, Colorado, USA.
Division of Cardiology, School of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
J Heart Lung Transplant. 2017 Jan;36(1):82-90. doi: 10.1016/j.healun.2016.08.013. Epub 2016 Aug 20.
Mechanical circulatory support (MCS) is a widely available management strategy. No studies have described sex differences in both extracorporeal and durable MCS. We analyzed sex-related differences of in-hospital outcomes for extracorporeal and durable MCS using administrative hospital data.
In total, 134.5 million hospital records between 1994 and 2012 were screened for placement of MCS using procedure codes of the International Classification of Diseases-9, Clinical Modification. Major adverse events (MAEs) were defined as death, major bleeding, stroke, device infection or mechanical complication. Participation in the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) registry was determined on an annual basis using quarterly reports of the INTERMACS. Associations between characteristics and outcomes were determined using multivariable logistic regression.
Sex was reported in 3,523 of 4,337 patients undergoing MCS placement from 45 INTERMACS sites (n = 1,383) and 246 non-INTERMACS sites (n = 2,954). Twenty-two percent were female. Baseline characteristics were significantly different with women being slightly younger (33.5% vs 27.4% age <50 years, p < 0.001; mean 55.7 ± 17.3 vs 56.1 ± 14.6 years) with fewer comorbidities. Women had higher rates of in-hospital mortality (52.3% vs 40.8%, p < 0.001) and MAEs (64.8% vs 52.5%, p < 0.001). Women had an 89% higher likelihood of MAEs when corrected for multivariate predictors (p < 0.001). In-hospital mortality decreased over time for both men and women (10% relative risk reduction/year, p < 0.001), but mortality in women was higher than in men throughout the study period.
There are significant sex differences in characteristics and outcomes of patients receiving MCS. Women had higher in-hospital mortality and were at increased risk of MAEs, which could not be explained by age or comorbid conditions. Further research on the causes of these disproportionate outcomes is needed.
机械循环支持(MCS)是一种广泛应用的治疗策略。尚无研究描述体外和长期MCS中的性别差异。我们使用医院管理数据分析了体外和长期MCS住院结局的性别相关差异。
利用国际疾病分类第9版临床修订本的程序编码,对1994年至2012年间的1.345亿份医院记录进行筛查,以确定MCS的植入情况。主要不良事件(MAE)定义为死亡、大出血、中风、器械感染或机械并发症。每年根据机械辅助循环支持机构间注册中心(INTERMACS)的季度报告确定是否参与该注册中心。使用多变量逻辑回归确定特征与结局之间的关联。
在来自45个INTERMACS中心(n = 1383)和246个非INTERMACS中心(n = 2954)的4337例接受MCS植入的患者中,有3523例报告了性别。22%为女性。基线特征存在显著差异,女性年龄稍小(年龄<50岁者占33.5% vs 27.4%,p < 0.001;平均年龄55.7±17.3岁 vs 56.1±14.6岁),合并症较少。女性的住院死亡率(52.3% vs 40.8%,p < 0.001)和MAE发生率(64.8% vs 52.5%,p < 0.001)较高。校正多变量预测因素后,女性发生MAE的可能性高89%(p < 0.001)。男性和女性的住院死亡率均随时间下降(每年相对风险降低10%,p < 0.001),但在整个研究期间,女性的死亡率高于男性。
接受MCS的患者在特征和结局方面存在显著的性别差异。女性的住院死亡率较高,发生MAE的风险增加,这不能用年龄或合并症来解释。需要对这些不成比例结局的原因进行进一步研究。